In a clinical investigation on NSCLC patients to examine the relationship between the severity of the major depressive disorder and EGFR mutation, the results indicated lower depression severity in EGFR-mutated NSCLC patients than with patients harboring wild-EGFR (Jacobs et al., 2017). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.